In toxicology, the use of PCCs must consider the patient's medical history, current medication, and the specific anticoagulant involved. It is crucial to assess the risk of thrombosis versus the benefit of reversing anticoagulation. Additionally, the type of PCC (three-factor vs. four-factor) and the specific clotting factors needed based on the toxicological profile should be carefully evaluated.
